CP
ELV icon

Castleview Partners’s Elevance Health ELV Stock Holding History

Castleview Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Sell
4,703
-353
-7% -$131K 0.8% 25
2026
Q1 		$1.48M Sell
5,056
-350
-6% -$115K 0.76% 28
2025
Q4 		$1.9M Sell
5,406
-1,237
-19% -$418K 0.94% 23
2025
Q3 		$2.15M Buy
6,643
+3,085
+87% +$959K 1.17% 21
2025
Q2 		$1.38M Buy
3,558
+390
+12% +$157K 0.89% 25
2025
Q1 		$1.38M Buy
3,168
+842
+36% +$338K 0.93% 23
2024
Q4 		$851K Buy
+2,326
New +$973K 0.46% 51
2024
Q3 		– Sell
-2
Closed -$1.08K – 647
2024
Q2 		$1.08K Hold
2
– – ﹤0.01% 803
2024
Q1 		$1.04K Buy
+2
New +$995 ﹤0.01% 794
2023
Q2 		– Sell
-35
Closed -$16.1K – 696
2023
Q1 		$16.1K Buy
+35
New +$16.7K 0.01% 367
2022
Q4 		– Sell
-70
Closed -$32K – 671
2022
Q3 		$32K Buy
+70
New +$33.5K 0.03% 294
2022
Q2 		– Sell
-70
Closed -$34K – 773
2022
Q1 		$34K Sell
70
-16,617
-100% -$7.6M 0.02% 387
2021
Q4 		$36 Buy
+16,687
New +$7.02M ﹤0.01% 909
2021
Q2 		$30K Buy
+78
New +$29.8K 0.01% 494

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Castleview Partners's ELV Position: Q2 2026 in Review

Castleview Partners reduced its Elevance Health (ELV) stake by 7% in Q2 2026, selling an estimated $131K and leaving 4,703 shares worth $1.82M. The position accounts for 0.8% of the portfolio, ranked #25.

Castleview Partners first reported a position in ELV in Q2 2021 and has held it in 14 quarters since. The position peaked at $2.15M in Q3 2025. 247 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Castleview Partners held 4,703 shares of Elevance Health worth $1.82M as of Q2 2026.
  • Castleview Partners sold 353 Elevance Health shares in Q2 2026, an estimated $131K.
  • Elevance Health made up 0.8% of Castleview Partners's portfolio in Q2 2026, its #25 holding.
  • Castleview Partners first reported a position in Elevance Health in Q2 2021 and has held it in 14 quarters since.
  • Castleview Partners's Elevance Health position peaked at $2.15M in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.